Machine Learning to Predict Long-Term Cardiac-Relative Prognosis in Patients With Extra-Cardiac Vascular Disease

Guisen Lin1,2, Qile Liu3, Yuchen Chen3

  • 1Department of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.

Insights

Machine learning accurately predicts long-term cardiac events in patients with ischemic stroke, transient ischemic attack, and peripheral artery disease. This approach surpasses traditional risk scores for identifying high-risk individuals needing intensified treatment.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Machine Learning

Background:

  • Patients with ischemic stroke (IS), transient ischemic attack (TIA), and peripheral artery disease (PAD) have a higher risk of coronary artery disease.
  • Accurate prognostic risk assessment is crucial for identifying high-risk patients who may benefit from intensified treatment.
  • Current risk stratification methods for this population remain challenging.

Purpose of the Study:

  • To evaluate the feasibility and predictive capability of machine learning (ML) models.
  • To predict long-term adverse cardiac outcomes in patients with IS, TIA, and/or PAD.
  • To compare ML performance against established clinical risk scores and CCTA metrics.

Main Methods:

  • Analysis of 636 patients with a history of IS, TIA, and/or PAD who underwent coronary CT angiography (CCTA).
  • Automated feature selection from 35 clinical variables and 34 CCTA metrics for ML model development.
  • Clinical outcomes included all-cause mortality (ACM) and major adverse cardiac events (MACE) over a mean follow-up of 3.9 years.

Main Results:

  • ML models demonstrated significantly higher predictive accuracy for ACM (AUC 0.92) and MACE (AUC 0.84) compared to modified Duke index, segment stenosis score, segment involvement score, and Framingham risk score.
  • Traditional risk scores showed lower predictive values for both ACM and MACE.
  • The study identified ML as a superior tool for risk prediction in this patient cohort.

Conclusions:

  • Machine learning models show superior capability in predicting long-term adverse cardiac outcomes (ACM and MACE) in patients with IS, TIA, and/or PAD.
  • ML surpasses traditional clinical risk scores and CCTA-derived metrics in prognostic accuracy for this high-risk population.
  • These findings suggest ML can enhance risk stratification and guide treatment decisions for patients with cerebrovascular and peripheral artery disease.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
61
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
86
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
60